Ministry of Finance press release · 26 May 2026 · pibtracker filter

M/s. Skymap Pharmaceuticals Private Ltd. is approved as Strategic Buyer for disinvestment of Indian Medicines Pharmaceutical Corporation Limited (IMPCL), a CPSE under the administrative control of M/o AYUSH

PRID2265581 MinistryMinistry of Finance Released26 May 2026 Reading9 min

Strategic disinvestment transaction was implemented through a two-stage competitive bidding process supported by a multi-layered consultative decision-making mechanism Posted On: 26 MAY 2026 7:01PM by PIB Delhi The Alternative Mechanism, a Group of Ministers empowered by the Cabinet Committee on Economic Affairs, comprising Union Cabinet Minister for Road Transport and Highways, Union Cabinet Minister for Finance and Union Minister of State (Independent Charge) for Ministry of AYUSH, have approved the highest bid amounting to Rs. 121,00,94,400 (One Hundred Twenty One Crores Ninety Four Thousand Four Hundred only) of M/s. Skymap Pharmaceuticals Private Limited for the sale of 100% equity shareholding of Indian Medicines Pharmaceutical Corporation Limited (IMPCL) along with transfer of management control. IMPCL was incorporated on July 12, 1978 with the prime objective of manufacturing and supplying standardised Ayurvedic and Unani Medicines. CCEA granted ‘in-principle’ approval in November, 2017 for the strategic disinvestment of entire equity shareholding of IMPCL to a strategic buyer to be identified through a two-stage bidding process. Following a competitive bidding process, professional advisers (Transaction Adviser, Legal Adviser, Asset Valuer) were appointed for the transaction. The Preliminary Information Memorandum (PIM) inviting Expression of Interest (EoI) from prospective bidders was issued on 01.09.2023, in response to which, 07 Interested Parties expressed interest, all of which were shortlisted as qualified bidders. Post-shortlisting, Qualified Interested Bidders (QIBs) conducted due diligence and the security clearance was obtained from the MHA. The Request for Proposal (RFP) along with Share Purchase Agreement (SPA) containing terms and conditions were issued on 01.12.2025 inviting technical and financial bids. Two sealed financial bids were received from the QIBs in response thereof, by the due date 20.01.2026. Both the bids were evaluated as per the prescribed procedure and found to be technically qualified. Thereafter, the technically qualified financial bids were opened in the presence of the representatives of the bidders. M/s. Skymap Pharmaceuticals Pvt. Ltd. emerged as the highest bidder at Rs. 121,00,94,400 (One Hundred Twenty-One Crores Ninety-Four Thousand Four Hundred only), which was also above the reserve price. The strategic disinvestment transaction was implemented through a two-stage open, competitive bidding process supported by a multi-layered consultative decision-making mechanism involving Inter-Ministerial Group, Core Group of Secretaries on Disinvestment and the empowered Alternative Mechanism. The Letter of Award has been issued to the Successful Bidder. Secretary, DIPAM and Secretary, AYUSH have been authorised to complete and close the transaction as early as possible. *** NB/KMN/GKP (Release ID: 2265581) Visitor Counter : 1533 Read this release in: Urdu , हिन्दी , Tamil , Telugu , Kannada Ministry of Finance M/s. Skymap Pharmaceuticals Private Ltd. is approved as Strategic Buyer for disinvestment of Indian Medicines Pharmaceutical Corporation Limited (IMPCL), a CPSE under the administrative control of M/o AYUSH Strategic disinvestment transaction was implemented through a two-stage competitive bidding process supported by a multi-layered consultative decision-making mechanism Posted On: 26 MAY 2026 7:01PM by PIB Delhi The Alternative Mechanism, a Group of Ministers empowered by the Cabinet Committee on Economic Affairs, comprising Union Cabinet Minister for Road Transport and Highways, Union Cabinet Minister for Finance and Union Minister of State (Independent Charge) for Ministry of AYUSH, have approved the highest bid amounting to Rs. 121,00,94,400 (One Hundred Twenty One Crores Ninety Four Thousand Four Hundred only) of M/s. Skymap Pharmaceuticals Private Limited for the sale of 100% equity shareholding of Indian Medicines Pharmaceutical Corporation Limited (IMPCL) along with transfer of management control. IMPCL was incorporated on July 12, 1978 with the prime objective of manufacturing and supplying standardised Ayurvedic and Unani Medicines. CCEA granted ‘in-principle’ approval in November, 2017 for the strategic disinvestment of entire equity shareholding of IMPCL to a strategic buyer to be identified through a two-stage bidding process. Following a competitive bidding process, professional advisers (Transaction Adviser, Legal Adviser, Asset Valuer) were appointed for the transaction. The Preliminary Information Memorandum (PIM) inviting Expression of Interest (EoI) from prospective bidders was issued on 01.09.2023, in response to which, 07 Interested Parties expressed interest, all of which were shortlisted as qualified bidders. Post-shortlisting, Qualified Interested Bidders (QIBs) conducted due diligence and the security clearance was obtained from the MHA. The Request for Proposal (RFP) along with Share Purchase Agreement (SPA) containing terms and conditions were issued on 01.12.2025 inviting technical and financial bids. Two sealed financial bids were received from the QIBs in response thereof, by the due date 20.01.2026. Both the bids were evaluated as per the prescribed procedure and found to be technically qualified. Thereafter, the technically qualified financial bids were opened in the presence of the representatives of the bidders. M/s. Skymap Pharmaceuticals Pvt. Ltd. emerged as the highest bidder at Rs. 121,00,94,400 (One Hundred Twenty-One Crores Ninety-Four Thousand Four Hundred only), which was also above the reserve price. The strategic disinvestment transaction was implemented through a two-stage open, competitive bidding process supported by a multi-layered consultative decision-making mechanism involving Inter-Ministerial Group, Core Group of Secretaries on Disinvestment and the empowered Alternative Mechanism. The Letter of Award has been issued to the Successful Bidder. Secretary, DIPAM and Secretary, AYUSH have been authorised to complete and close the transaction as early as possible. *** NB/KMN/GKP (Release ID: 2265581) Strategic disinvestment transaction was implemented through a two-stage competitive bidding process supported by a multi-layered consultative decision-making mechanism" /> The Alternative Mechanism, a Group of Ministers empowered by the Cabinet Committee on Economic Affairs, comprising Union Cabinet Minister for Road Transport and Highways, Union Cabinet Minister for Finance and Union Minister of State (Independent Charge) for Ministry of AYUSH, have approved the highest bid amounting to Rs. 121,00,94,400 (One Hundred Twenty One Crores Ninety Four Thousand Four Hundred only) of M/s. Skymap Pharmaceuticals Private Limited for the sale of 100% equity shareholding of Indian Medicines Pharmaceutical Corporation Limited (IMPCL) along with transfer of management control. IMPCL was incorporated on July 12, 1978 with the prime objective of manufacturing and supplying standardised Ayurvedic and Unani Medicines. CCEA granted ‘in-principle’ approval in November, 2017 for the strategic disinvestment of entire equity shareholding of IMPCL to a strategic buyer to be identified through a two-stage bidding process. Following a competitive bidding process, professional advisers (Transaction Adviser, Legal Adviser, Asset Valuer) were appointed for the transaction. The Preliminary Information Memorandum (PIM) inviting Expression of Interest (EoI) from prospective bidders was issued on 01.09.2023, in response to which, 07 Interested Parties expressed interest, all of which were shortlisted as qualified bidders. Post-shortlisting, Qualified Interested Bidders (QIBs) conducted due diligence and the security clearance was obtained from the MHA. The Request for Proposal (RFP) along with Share Purchase Agreement (SPA) containing terms and conditions were issued on 01.12.2025 inviting technical and financial bids. Two sealed financial bids were received from the QIBs in response thereof, by the due date 20.01.2026. Both the bids were evaluated as per the prescribed procedure and found to be technically qualified. Thereafter, the technically qualified financial bids were opened in the presence of the representatives of the bidders. M/s. Skymap Pharmaceuticals Pvt. Ltd. emerged as the highest bidder at Rs. 121,00,94,400 (One Hundred Twenty-One Crores Ninety-Four Thousand Four Hundred only), which was also above the reserve price.  The strategic disinvestment transaction was implemented through a two-stage open, competitive bidding process supported by a multi-layered consultative decision-making mechanism involving Inter-Ministerial Group, Core Group of Secretaries on Disinvestment and the empowered Alternative Mechanism. The Letter of Award has been issued to the Successful Bidder. Secretary, DIPAM and Secretary, AYUSH have been authorised to complete and close the transaction as early as possible. *** NB/KMN/GKP " /> var mPlayer = document.getElementById("background_music"); var mPlayAction = document.getElementById("playbutton"); var isPlaying = false; function playAudio() { mPlayer.play(); isPlaying = true; document.getElementById('stopA').style.display = "block"; document.getElementById('playA').style.display = "none"; } function pauseAudio() { mPlayer.pause(); isPlaying = false; document.getElementById('playA').style.display = "block"; document.getElementById('stopA').style.display = "none"; } //function HandleAudio() { // if (isPlaying == true) { // //Playing already Pause it // pauseAudio(); // } else { // //Play the music // playAudio(); // } //} var synth = window.speechSynthesis; function CleanHtml(html) { html = html.replace(/ /gi, ''); return html; } function stripHtml(html) { let tmp = document.createElement("DIV"); tmp.innerHTML = CleanHtml(html); return tmp.textContent || tmp.innerText || ""; } $(document).ready(function () { //for responsive tables $("table").each(function () { if (!$(this).closest(".table-responsive").length) { $(this).wrap(" "); } }); var width = $(window).width(); if (width $(document).ready(function () { var width = $(window).width(); if (width @media print { .sticky-social, .sticky-social_mb, .pull-right, #printPDF { display: none !important; } } .f_vl { padding-right: 30px; font-size: 17px; cursor: pointer; } .log_oo { // width: 20%; display: flex; justify-content: space-between; } .log_oo img { width: 150px; /*width: 100%; height: auto;*/ } .sticky-social_mb { position: fixed; bottom: 0px; padding: 0px; margin: 0px; width: 100%; } .social_mb { list-style: none; display: flex; width: 100%; margin-bottom: -8px; } .social_mb a { padding: 8px 0px; font-size: 30px; transition: all 0.8s ease-in-out; width: 20% !important; text-align: center; } .section1 { position: relative; padding: 10px 0px; width: 100%; } .sticky-social { position: fixed; top: 20px; left: 0px; padding: 0px; margin: 0px; } .social { list-style: none; } .social a li { padding: 8px 12px; font-size: 25px; transition: all 0.8s ease-in-out; } .social a li:hover { margin-right: -30px; box-shadow: 2px 5px 10px grey; } .social a li:hover .fa { margin-left: 20px; } .fb_b { /* background-color: rgb(59, 89, 152);*/ background-color: rgba(65,103,178,255); } .twitter_r { /* background-color: rgb(29, 161, 242);*/ background-color: #000000; } .whatsapp_r { /* background-color: rgb(77, 194, 71);*/ background-color: rgba(13,191,67,255); } .fa-envelope_r { /* background-color: rgb(219, 68, 55);*/ background-color: #e2123d; } .fa-linkedin_r { background-color: rgb(0, 119, 181); } @media only screen and (max-device-width: 767px) { p span img { max-width: 90% !important; height: auto !important; } p img { max-width: 90% !important; height: auto !important; } h2 { font-size: 20px !important; font-weight: 600 !important; } h3 { font-size: 18px !important; font-weight: 600 !important; } } /* === Film Roll Badge Styling(IFFI2025 countdown) === */ .film-roll-badge { position: absolute; top:82%; right: 20px; width: 230px; height: 70px; background: repeating-linear-gradient( to right, #9a2375 0px, #9a2375 18px, #6e2b8b 18px, #6e2b8b 36px ); border-top: 8px solid #9a2375; border-bottom: 8px solid #9a2375; border-radius: 8px; overflow: hidden; box-shadow: 0 4px 12px rgba(0, 0, 0, 0.4); animation: moveFilm 8s linear infinite; z-index: 10; } /* film sprocket holes */ .film-roll-badge::before, .film-roll-badge::after { content: ""; position: absolute; width: 100%; height: 10px; background: repeating-linear-gradient( to right, #9a2375 0px, #9a2375 10px, #fff 10px, #fff 20px ); left: 0; z-index: 2; } .film-roll-badge::before { top: -4px; } .film-roll-badge::after { bottom: -4px; } .film-roll-inner { position: relative; height: 100%; display: flex; align-items: center; justify-content: center; animation: flicker 2s infinite ease-in-out; } .countdown-text { font-size: 1.3rem; font-weight: 700; color: #fff; text-shadow: 0 0 6px rgba(255, 255, 255, 0.4), 0 0 10px #000; white-space: nowrap; } /* === Animations === */ @keyframes moveFilm { 0% { background-position: 0 0; } 100% { background-position: 120px 0; } } @keyframes flicker { 0%, 100% { opacity: 1; } 50% { opacity: 0.9; } 25% { opacity: 0.95; } 75% { opacity: 0.85; } } /* === Responsive Adjustments === */ @media (max-width: 1500px) { .film-roll-badge { top: 68%; right: 18px; /* width: 220px; */ height: 65px; font-size: 0.85rem; } .press-section { margin-top: 35px; } } @media (max-width: 992px) { .film-roll-badge { top: 52%; right: 10px; width: 200px; height: 60px; } } @media (max-width: 768px) { .film-roll-badge { top: 56%; right: 10px; width: 124px; height: 55px; } .countdown-text { font-size: 0.9rem; } } @media (max-width: 576px) { .film-roll-badge { top: 59%; right: 5px; /* width: 160px; */ height: 50px; } .countdown-text { font-size: 0.85rem; } } const festivalStart = new Date("2025-11-20T00:00:00").getTime(); const festivalEnd = new Date("2025-11-28T23:59:59").getTime(); const countdownElement = document.getElementById("countdown"); const interval = setInterval(() => { const now = new Date().getTime(); // BEFORE FESTIVAL — show days + hours left if (now = festivalStart && now el.style.width = "350px"); clearInterval(interval); } }, 1000); //

Original PIB release
pib.gov.in · PRID 2265581

Open on PIB ↗

M/s. Skymap Pharmaceuticals Private Ltd. is approved as Strategic Buyer for disinvestment of Indian Medicines Pharmaceutical Corporation Limited (IMPCL), a CPSE under the administrative control of M/o AYUSH

More from this day